Disease X Act of 2023
This bill expands the priorities of the Biomedical Advanced Research and Development Authority (BARDA) to specifically include viral threats that have the potential to cause a pandemic.
In particular, the bill expands the scope of innovation grants and contracts that may be awarded by BARDA to specifically include those that support research and development of certain manufacturing technology for medical countermeasures against viruses, including respiratory viruses, with pandemic potential. It also expands BARDA's authorized strategic initiatives to include advanced research, development, and procurement of countermeasures and products to address viruses with pandemic potential.
[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3832 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 3832
To establish a program at BARDA for developing medical countermeasures
for viral threats with pandemic potential.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 5, 2023
Mrs. Trahan (for herself, Mr. Burgess, Mr. Crenshaw, and Ms. Lee of
Nevada) introduced the following bill; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To establish a program at BARDA for developing medical countermeasures
for viral threats with pandemic potential.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Disease X Act of 2023''.
SEC. 2. MEDICAL COUNTERMEASURES FOR VIRAL THREATS WITH PANDEMIC
POTENTIAL.
Section 319L(c)(4) of the Public Health Service Act (42 U.S.C.
247d-7e(c)(4)) is amended--
(1) in subparagraph (D)--
(A) in clause (ii), by striking ``; and'' and
inserting a semicolon;
(B) by redesignating clause (iii) as clause (v);
and
(C) by inserting after clause (ii) the following:
``(iii) the identification and development
of platform manufacturing technologies needed
for advanced development and manufacturing of
medical countermeasures for viral families
which have significant potential to cause a
pandemic;
``(iv) advanced research and development of
flexible medical countermeasures against
priority respiratory virus families and other
respiratory viral pathogens with a significant
potential to cause a pandemic, with both
pathogen-specific and pathogen-agnostic
approaches; and''; and
(2) in subparagraph (F)--
(A) in clause (ii), by striking ``; and'' at the
end and inserting a semicolon;
(B) in clause (iii), by striking the period and
inserting ``; and''; and
(C) by adding at the end the following:
``(iv) priority virus families and other
viral pathogens with a significant potential to
cause a pandemic.''.
<all>
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line